Skip to content
Search

Latest Stories

Market Exit: PCSE takes over administration of pharmacy premises withdrawal

Market Exit: PCSE takes over administration of pharmacy premises withdrawal

Any pharmacy premises withdrawal requests submitted before 1st July 2024 will still be processed directly by the respective integrated care board  

From today, Primary Care Support England (PCSE) will manage the administration and processing of notices of withdrawal from a pharmaceutical list.


Pharmacy and dispensing appliance contractors who wish to withdraw their premises must now submit closure notification forms to PCSE, which will forward them to the relevant integrated care board (ICB).

Withdrawal notices should be sent to pcse.marketentry@nhs.net.

NHS England announced PCSE's new role last week.

For permanent closure of premises, pharmacies with 40 core opening hours, those with more than 40 core opening hours under a direction, and dispensing appliance contractors are required to give a minimum notice period of three months.

Pharmacies that operate or have operated under the 100-hour condition must provide at least six months' notice.

Under regulation 67 of the NHS (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013, as amended, if it is impracticable for contractors to provide the required notice period, they must inform NHS England (or the ICB in whose area the premises are located from 1 April 2023) as soon as it is practicable to do so.

Additionally, the ICB can agree to a shorter notice period.

Closure of premises notification should be completed by contractors where they wish to withdraw premises from a pharmaceutical list. This form is not applicable to contractors operating under a local pharmaceutical services (LPS) contract or dispensing doctors looking to withdraw premises from a dispensing doctor list.

Any withdrawal requests submitted before 1 July 2024 will still be processed directly by the ICB, and any related inquiries should be addressed to the respective ICB.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less